ArticleJournal of Cancer2021

High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia.

Shuang-Hui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.